nodes	percent_of_prediction	percent_of_DWPC	metapath
Trandolapril—Epistaxis—Methotrexate—bone cancer	0.00206	0.00206	CcSEcCtD
Trandolapril—Drowsiness—Epirubicin—bone cancer	0.00204	0.00204	CcSEcCtD
Trandolapril—Infestation—Epirubicin—bone cancer	0.00204	0.00204	CcSEcCtD
Trandolapril—Infestation NOS—Epirubicin—bone cancer	0.00204	0.00204	CcSEcCtD
Trandolapril—Bronchitis—Doxorubicin—bone cancer	0.00204	0.00204	CcSEcCtD
Trandolapril—Agranulocytosis—Methotrexate—bone cancer	0.00204	0.00204	CcSEcCtD
Trandolapril—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.00202	0.00202	CcSEcCtD
Trandolapril—Pancytopenia—Doxorubicin—bone cancer	0.00201	0.00201	CcSEcCtD
Trandolapril—Renal failure—Epirubicin—bone cancer	0.00201	0.00201	CcSEcCtD
Trandolapril—Body temperature increased—Cisplatin—bone cancer	0.002	0.00201	CcSEcCtD
Trandolapril—Urinary tract infection—Epirubicin—bone cancer	0.00198	0.00199	CcSEcCtD
Trandolapril—Neutropenia—Doxorubicin—bone cancer	0.00198	0.00198	CcSEcCtD
Trandolapril—Upper respiratory tract infection—Doxorubicin—bone cancer	0.00197	0.00197	CcSEcCtD
Trandolapril—Hepatitis—Methotrexate—bone cancer	0.00196	0.00196	CcSEcCtD
Trandolapril—Sweating—Epirubicin—bone cancer	0.00196	0.00196	CcSEcCtD
Trandolapril—Pollakiuria—Doxorubicin—bone cancer	0.00196	0.00196	CcSEcCtD
Trandolapril—Pharyngitis—Methotrexate—bone cancer	0.00194	0.00194	CcSEcCtD
Trandolapril—Urinary tract disorder—Methotrexate—bone cancer	0.00193	0.00193	CcSEcCtD
Trandolapril—Photosensitivity reaction—Doxorubicin—bone cancer	0.00193	0.00193	CcSEcCtD
Trandolapril—Hepatobiliary disease—Epirubicin—bone cancer	0.00193	0.00193	CcSEcCtD
Trandolapril—Epistaxis—Epirubicin—bone cancer	0.00193	0.00193	CcSEcCtD
Trandolapril—Urethral disorder—Methotrexate—bone cancer	0.00192	0.00192	CcSEcCtD
Trandolapril—Hyperglycaemia—Doxorubicin—bone cancer	0.00191	0.00191	CcSEcCtD
Trandolapril—Agranulocytosis—Epirubicin—bone cancer	0.00191	0.00191	CcSEcCtD
Trandolapril—Infestation—Doxorubicin—bone cancer	0.00189	0.00189	CcSEcCtD
Trandolapril—Infestation NOS—Doxorubicin—bone cancer	0.00189	0.00189	CcSEcCtD
Trandolapril—Drowsiness—Doxorubicin—bone cancer	0.00189	0.00189	CcSEcCtD
Trandolapril—Visual impairment—Methotrexate—bone cancer	0.00189	0.00189	CcSEcCtD
Trandolapril—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.00187	0.00187	CcSEcCtD
Trandolapril—Hypersensitivity—Cisplatin—bone cancer	0.00187	0.00187	CcSEcCtD
Trandolapril—Bradycardia—Epirubicin—bone cancer	0.00187	0.00187	CcSEcCtD
Trandolapril—Renal failure—Doxorubicin—bone cancer	0.00186	0.00186	CcSEcCtD
Trandolapril—Erythema multiforme—Methotrexate—bone cancer	0.00185	0.00185	CcSEcCtD
Trandolapril—Rhinitis—Epirubicin—bone cancer	0.00184	0.00184	CcSEcCtD
Trandolapril—Urinary tract infection—Doxorubicin—bone cancer	0.00184	0.00184	CcSEcCtD
Trandolapril—Hepatitis—Epirubicin—bone cancer	0.00183	0.00183	CcSEcCtD
Trandolapril—Eye disorder—Methotrexate—bone cancer	0.00183	0.00183	CcSEcCtD
Trandolapril—Tinnitus—Methotrexate—bone cancer	0.00183	0.00183	CcSEcCtD
Trandolapril—Asthenia—Cisplatin—bone cancer	0.00182	0.00182	CcSEcCtD
Trandolapril—Pharyngitis—Epirubicin—bone cancer	0.00182	0.00182	CcSEcCtD
Trandolapril—Cardiac disorder—Methotrexate—bone cancer	0.00182	0.00182	CcSEcCtD
Trandolapril—Sweating—Doxorubicin—bone cancer	0.00181	0.00181	CcSEcCtD
Trandolapril—Urinary tract disorder—Epirubicin—bone cancer	0.00181	0.00181	CcSEcCtD
Trandolapril—Oedema peripheral—Epirubicin—bone cancer	0.00181	0.00181	CcSEcCtD
Trandolapril—Connective tissue disorder—Epirubicin—bone cancer	0.0018	0.0018	CcSEcCtD
Trandolapril—Urethral disorder—Epirubicin—bone cancer	0.0018	0.0018	CcSEcCtD
Trandolapril—Hepatobiliary disease—Doxorubicin—bone cancer	0.00179	0.00179	CcSEcCtD
Trandolapril—Epistaxis—Doxorubicin—bone cancer	0.00178	0.00178	CcSEcCtD
Trandolapril—Angiopathy—Methotrexate—bone cancer	0.00178	0.00178	CcSEcCtD
Trandolapril—Immune system disorder—Methotrexate—bone cancer	0.00177	0.00177	CcSEcCtD
Trandolapril—Visual impairment—Epirubicin—bone cancer	0.00177	0.00177	CcSEcCtD
Trandolapril—Mediastinal disorder—Methotrexate—bone cancer	0.00177	0.00177	CcSEcCtD
Trandolapril—Agranulocytosis—Doxorubicin—bone cancer	0.00176	0.00176	CcSEcCtD
Trandolapril—Diarrhoea—Cisplatin—bone cancer	0.00174	0.00174	CcSEcCtD
Trandolapril—Erythema multiforme—Epirubicin—bone cancer	0.00173	0.00173	CcSEcCtD
Trandolapril—Alopecia—Methotrexate—bone cancer	0.00173	0.00173	CcSEcCtD
Trandolapril—Bradycardia—Doxorubicin—bone cancer	0.00173	0.00173	CcSEcCtD
Trandolapril—Mental disorder—Methotrexate—bone cancer	0.00172	0.00172	CcSEcCtD
Trandolapril—Eye disorder—Epirubicin—bone cancer	0.00171	0.00171	CcSEcCtD
Trandolapril—Tinnitus—Epirubicin—bone cancer	0.00171	0.00171	CcSEcCtD
Trandolapril—Malnutrition—Methotrexate—bone cancer	0.00171	0.00171	CcSEcCtD
Trandolapril—Cardiac disorder—Epirubicin—bone cancer	0.0017	0.0017	CcSEcCtD
Trandolapril—Flushing—Epirubicin—bone cancer	0.0017	0.0017	CcSEcCtD
Trandolapril—Rhinitis—Doxorubicin—bone cancer	0.0017	0.0017	CcSEcCtD
Trandolapril—Hepatitis—Doxorubicin—bone cancer	0.0017	0.0017	CcSEcCtD
Trandolapril—Pharyngitis—Doxorubicin—bone cancer	0.00168	0.00168	CcSEcCtD
Trandolapril—Urinary tract disorder—Doxorubicin—bone cancer	0.00167	0.00168	CcSEcCtD
Trandolapril—Oedema peripheral—Doxorubicin—bone cancer	0.00167	0.00167	CcSEcCtD
Trandolapril—Dysgeusia—Methotrexate—bone cancer	0.00167	0.00167	CcSEcCtD
Trandolapril—Connective tissue disorder—Doxorubicin—bone cancer	0.00167	0.00167	CcSEcCtD
Trandolapril—Angiopathy—Epirubicin—bone cancer	0.00166	0.00166	CcSEcCtD
Trandolapril—Urethral disorder—Doxorubicin—bone cancer	0.00166	0.00166	CcSEcCtD
Trandolapril—Immune system disorder—Epirubicin—bone cancer	0.00166	0.00166	CcSEcCtD
Trandolapril—Mediastinal disorder—Epirubicin—bone cancer	0.00165	0.00165	CcSEcCtD
Trandolapril—Back pain—Methotrexate—bone cancer	0.00165	0.00165	CcSEcCtD
Trandolapril—Arrhythmia—Epirubicin—bone cancer	0.00164	0.00164	CcSEcCtD
Trandolapril—Visual impairment—Doxorubicin—bone cancer	0.00163	0.00163	CcSEcCtD
Trandolapril—Alopecia—Epirubicin—bone cancer	0.00162	0.00162	CcSEcCtD
Trandolapril—Vomiting—Cisplatin—bone cancer	0.00161	0.00161	CcSEcCtD
Trandolapril—Mental disorder—Epirubicin—bone cancer	0.00161	0.00161	CcSEcCtD
Trandolapril—Erythema multiforme—Doxorubicin—bone cancer	0.0016	0.0016	CcSEcCtD
Trandolapril—Rash—Cisplatin—bone cancer	0.0016	0.0016	CcSEcCtD
Trandolapril—Dermatitis—Cisplatin—bone cancer	0.0016	0.0016	CcSEcCtD
Trandolapril—Malnutrition—Epirubicin—bone cancer	0.0016	0.0016	CcSEcCtD
Trandolapril—Eye disorder—Doxorubicin—bone cancer	0.00158	0.00159	CcSEcCtD
Trandolapril—Ill-defined disorder—Methotrexate—bone cancer	0.00158	0.00158	CcSEcCtD
Trandolapril—Tinnitus—Doxorubicin—bone cancer	0.00158	0.00158	CcSEcCtD
Trandolapril—Anaemia—Methotrexate—bone cancer	0.00158	0.00158	CcSEcCtD
Trandolapril—Flushing—Doxorubicin—bone cancer	0.00157	0.00157	CcSEcCtD
Trandolapril—Cardiac disorder—Doxorubicin—bone cancer	0.00157	0.00157	CcSEcCtD
Trandolapril—Flatulence—Epirubicin—bone cancer	0.00157	0.00157	CcSEcCtD
Trandolapril—Dysgeusia—Epirubicin—bone cancer	0.00156	0.00156	CcSEcCtD
Trandolapril—Back pain—Epirubicin—bone cancer	0.00154	0.00154	CcSEcCtD
Trandolapril—Angiopathy—Doxorubicin—bone cancer	0.00154	0.00154	CcSEcCtD
Trandolapril—Malaise—Methotrexate—bone cancer	0.00154	0.00154	CcSEcCtD
Trandolapril—Muscle spasms—Epirubicin—bone cancer	0.00153	0.00153	CcSEcCtD
Trandolapril—Immune system disorder—Doxorubicin—bone cancer	0.00153	0.00153	CcSEcCtD
Trandolapril—Vertigo—Methotrexate—bone cancer	0.00153	0.00153	CcSEcCtD
Trandolapril—Mediastinal disorder—Doxorubicin—bone cancer	0.00153	0.00153	CcSEcCtD
Trandolapril—Leukopenia—Methotrexate—bone cancer	0.00153	0.00153	CcSEcCtD
Trandolapril—Arrhythmia—Doxorubicin—bone cancer	0.00152	0.00152	CcSEcCtD
Trandolapril—Nausea—Cisplatin—bone cancer	0.00151	0.00151	CcSEcCtD
Trandolapril—Alopecia—Doxorubicin—bone cancer	0.0015	0.0015	CcSEcCtD
Trandolapril—Cough—Methotrexate—bone cancer	0.00149	0.00149	CcSEcCtD
Trandolapril—Mental disorder—Doxorubicin—bone cancer	0.00149	0.00149	CcSEcCtD
Trandolapril—Ill-defined disorder—Epirubicin—bone cancer	0.00148	0.00148	CcSEcCtD
Trandolapril—Malnutrition—Doxorubicin—bone cancer	0.00148	0.00148	CcSEcCtD
Trandolapril—Anaemia—Epirubicin—bone cancer	0.00147	0.00148	CcSEcCtD
Trandolapril—Agitation—Epirubicin—bone cancer	0.00147	0.00147	CcSEcCtD
Trandolapril—Flatulence—Doxorubicin—bone cancer	0.00145	0.00146	CcSEcCtD
Trandolapril—Chest pain—Methotrexate—bone cancer	0.00145	0.00145	CcSEcCtD
Trandolapril—Arthralgia—Methotrexate—bone cancer	0.00145	0.00145	CcSEcCtD
Trandolapril—Myalgia—Methotrexate—bone cancer	0.00145	0.00145	CcSEcCtD
Trandolapril—Dysgeusia—Doxorubicin—bone cancer	0.00145	0.00145	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00144	0.00144	CcSEcCtD
Trandolapril—Malaise—Epirubicin—bone cancer	0.00144	0.00144	CcSEcCtD
Trandolapril—Discomfort—Methotrexate—bone cancer	0.00143	0.00143	CcSEcCtD
Trandolapril—Vertigo—Epirubicin—bone cancer	0.00143	0.00143	CcSEcCtD
Trandolapril—Syncope—Epirubicin—bone cancer	0.00143	0.00143	CcSEcCtD
Trandolapril—Leukopenia—Epirubicin—bone cancer	0.00143	0.00143	CcSEcCtD
Trandolapril—Back pain—Doxorubicin—bone cancer	0.00143	0.00143	CcSEcCtD
Trandolapril—Muscle spasms—Doxorubicin—bone cancer	0.00142	0.00142	CcSEcCtD
Trandolapril—Palpitations—Epirubicin—bone cancer	0.00141	0.00141	CcSEcCtD
Trandolapril—Loss of consciousness—Epirubicin—bone cancer	0.0014	0.0014	CcSEcCtD
Trandolapril—Cough—Epirubicin—bone cancer	0.00139	0.00139	CcSEcCtD
Trandolapril—Infection—Methotrexate—bone cancer	0.00138	0.00138	CcSEcCtD
Trandolapril—Ill-defined disorder—Doxorubicin—bone cancer	0.00137	0.00137	CcSEcCtD
Trandolapril—Nervous system disorder—Methotrexate—bone cancer	0.00136	0.00137	CcSEcCtD
Trandolapril—Anaemia—Doxorubicin—bone cancer	0.00136	0.00136	CcSEcCtD
Trandolapril—Thrombocytopenia—Methotrexate—bone cancer	0.00136	0.00136	CcSEcCtD
Trandolapril—Arthralgia—Epirubicin—bone cancer	0.00136	0.00136	CcSEcCtD
Trandolapril—Chest pain—Epirubicin—bone cancer	0.00136	0.00136	CcSEcCtD
Trandolapril—Myalgia—Epirubicin—bone cancer	0.00136	0.00136	CcSEcCtD
Trandolapril—Agitation—Doxorubicin—bone cancer	0.00136	0.00136	CcSEcCtD
Trandolapril—Anxiety—Epirubicin—bone cancer	0.00135	0.00135	CcSEcCtD
Trandolapril—Skin disorder—Methotrexate—bone cancer	0.00135	0.00135	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00135	0.00135	CcSEcCtD
Trandolapril—Hyperhidrosis—Methotrexate—bone cancer	0.00135	0.00135	CcSEcCtD
Trandolapril—Discomfort—Epirubicin—bone cancer	0.00134	0.00134	CcSEcCtD
Trandolapril—Malaise—Doxorubicin—bone cancer	0.00133	0.00133	CcSEcCtD
Trandolapril—Dry mouth—Epirubicin—bone cancer	0.00133	0.00133	CcSEcCtD
Trandolapril—Vertigo—Doxorubicin—bone cancer	0.00133	0.00133	CcSEcCtD
Trandolapril—Anorexia—Methotrexate—bone cancer	0.00133	0.00133	CcSEcCtD
Trandolapril—Syncope—Doxorubicin—bone cancer	0.00132	0.00132	CcSEcCtD
Trandolapril—Leukopenia—Doxorubicin—bone cancer	0.00132	0.00132	CcSEcCtD
Trandolapril—Palpitations—Doxorubicin—bone cancer	0.0013	0.00131	CcSEcCtD
Trandolapril—Oedema—Epirubicin—bone cancer	0.0013	0.0013	CcSEcCtD
Trandolapril—Hypotension—Methotrexate—bone cancer	0.0013	0.0013	CcSEcCtD
Trandolapril—Loss of consciousness—Doxorubicin—bone cancer	0.0013	0.0013	CcSEcCtD
Trandolapril—Infection—Epirubicin—bone cancer	0.00129	0.00129	CcSEcCtD
Trandolapril—Cough—Doxorubicin—bone cancer	0.00129	0.00129	CcSEcCtD
Trandolapril—Shock—Epirubicin—bone cancer	0.00128	0.00128	CcSEcCtD
Trandolapril—Nervous system disorder—Epirubicin—bone cancer	0.00128	0.00128	CcSEcCtD
Trandolapril—Thrombocytopenia—Epirubicin—bone cancer	0.00128	0.00128	CcSEcCtD
Trandolapril—Tachycardia—Epirubicin—bone cancer	0.00127	0.00127	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00127	0.00127	CcSEcCtD
Trandolapril—Skin disorder—Epirubicin—bone cancer	0.00126	0.00127	CcSEcCtD
Trandolapril—Hyperhidrosis—Epirubicin—bone cancer	0.00126	0.00126	CcSEcCtD
Trandolapril—Insomnia—Methotrexate—bone cancer	0.00126	0.00126	CcSEcCtD
Trandolapril—Arthralgia—Doxorubicin—bone cancer	0.00126	0.00126	CcSEcCtD
Trandolapril—Myalgia—Doxorubicin—bone cancer	0.00126	0.00126	CcSEcCtD
Trandolapril—Chest pain—Doxorubicin—bone cancer	0.00126	0.00126	CcSEcCtD
Trandolapril—Anxiety—Doxorubicin—bone cancer	0.00125	0.00125	CcSEcCtD
Trandolapril—Paraesthesia—Methotrexate—bone cancer	0.00125	0.00125	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00125	0.00125	CcSEcCtD
Trandolapril—Discomfort—Doxorubicin—bone cancer	0.00124	0.00124	CcSEcCtD
Trandolapril—Anorexia—Epirubicin—bone cancer	0.00124	0.00124	CcSEcCtD
Trandolapril—Dyspnoea—Methotrexate—bone cancer	0.00124	0.00124	CcSEcCtD
Trandolapril—Somnolence—Methotrexate—bone cancer	0.00124	0.00124	CcSEcCtD
Trandolapril—Dry mouth—Doxorubicin—bone cancer	0.00123	0.00123	CcSEcCtD
Trandolapril—Dyspepsia—Methotrexate—bone cancer	0.00122	0.00123	CcSEcCtD
Trandolapril—Hypotension—Epirubicin—bone cancer	0.00122	0.00122	CcSEcCtD
Trandolapril—Decreased appetite—Methotrexate—bone cancer	0.00121	0.00121	CcSEcCtD
Trandolapril—Oedema—Doxorubicin—bone cancer	0.0012	0.00121	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Methotrexate—bone cancer	0.0012	0.0012	CcSEcCtD
Trandolapril—Fatigue—Methotrexate—bone cancer	0.0012	0.0012	CcSEcCtD
Trandolapril—Infection—Doxorubicin—bone cancer	0.0012	0.0012	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Epirubicin—bone cancer	0.00119	0.00119	CcSEcCtD
Trandolapril—Shock—Doxorubicin—bone cancer	0.00119	0.00119	CcSEcCtD
Trandolapril—Nervous system disorder—Doxorubicin—bone cancer	0.00118	0.00118	CcSEcCtD
Trandolapril—Thrombocytopenia—Doxorubicin—bone cancer	0.00118	0.00118	CcSEcCtD
Trandolapril—Insomnia—Epirubicin—bone cancer	0.00118	0.00118	CcSEcCtD
Trandolapril—Tachycardia—Doxorubicin—bone cancer	0.00118	0.00118	CcSEcCtD
Trandolapril—Skin disorder—Doxorubicin—bone cancer	0.00117	0.00117	CcSEcCtD
Trandolapril—Paraesthesia—Epirubicin—bone cancer	0.00117	0.00117	CcSEcCtD
Trandolapril—Hyperhidrosis—Doxorubicin—bone cancer	0.00116	0.00117	CcSEcCtD
Trandolapril—Dyspnoea—Epirubicin—bone cancer	0.00116	0.00116	CcSEcCtD
Trandolapril—Somnolence—Epirubicin—bone cancer	0.00116	0.00116	CcSEcCtD
Trandolapril—Anorexia—Doxorubicin—bone cancer	0.00115	0.00115	CcSEcCtD
Trandolapril—Feeling abnormal—Methotrexate—bone cancer	0.00115	0.00115	CcSEcCtD
Trandolapril—Dyspepsia—Epirubicin—bone cancer	0.00115	0.00115	CcSEcCtD
Trandolapril—Gastrointestinal pain—Methotrexate—bone cancer	0.00114	0.00114	CcSEcCtD
Trandolapril—Decreased appetite—Epirubicin—bone cancer	0.00113	0.00113	CcSEcCtD
Trandolapril—Hypotension—Doxorubicin—bone cancer	0.00113	0.00113	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Epirubicin—bone cancer	0.00112	0.00112	CcSEcCtD
Trandolapril—Fatigue—Epirubicin—bone cancer	0.00112	0.00112	CcSEcCtD
Trandolapril—Constipation—Epirubicin—bone cancer	0.00111	0.00111	CcSEcCtD
Trandolapril—Urticaria—Methotrexate—bone cancer	0.00111	0.00111	CcSEcCtD
Trandolapril—Abdominal pain—Methotrexate—bone cancer	0.0011	0.0011	CcSEcCtD
Trandolapril—Body temperature increased—Methotrexate—bone cancer	0.0011	0.0011	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.0011	0.0011	CcSEcCtD
Trandolapril—Insomnia—Doxorubicin—bone cancer	0.00109	0.00109	CcSEcCtD
Trandolapril—Paraesthesia—Doxorubicin—bone cancer	0.00108	0.00108	CcSEcCtD
Trandolapril—Dyspnoea—Doxorubicin—bone cancer	0.00107	0.00107	CcSEcCtD
Trandolapril—Feeling abnormal—Epirubicin—bone cancer	0.00107	0.00107	CcSEcCtD
Trandolapril—Somnolence—Doxorubicin—bone cancer	0.00107	0.00107	CcSEcCtD
Trandolapril—Gastrointestinal pain—Epirubicin—bone cancer	0.00106	0.00107	CcSEcCtD
Trandolapril—Dyspepsia—Doxorubicin—bone cancer	0.00106	0.00106	CcSEcCtD
Trandolapril—Decreased appetite—Doxorubicin—bone cancer	0.00105	0.00105	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00104	0.00104	CcSEcCtD
Trandolapril—Fatigue—Doxorubicin—bone cancer	0.00104	0.00104	CcSEcCtD
Trandolapril—Urticaria—Epirubicin—bone cancer	0.00103	0.00103	CcSEcCtD
Trandolapril—Constipation—Doxorubicin—bone cancer	0.00103	0.00103	CcSEcCtD
Trandolapril—Abdominal pain—Epirubicin—bone cancer	0.00103	0.00103	CcSEcCtD
Trandolapril—Body temperature increased—Epirubicin—bone cancer	0.00103	0.00103	CcSEcCtD
Trandolapril—Hypersensitivity—Methotrexate—bone cancer	0.00103	0.00103	CcSEcCtD
Trandolapril—Asthenia—Methotrexate—bone cancer	0.000998	0.000999	CcSEcCtD
Trandolapril—Feeling abnormal—Doxorubicin—bone cancer	0.000993	0.000993	CcSEcCtD
Trandolapril—Gastrointestinal pain—Doxorubicin—bone cancer	0.000985	0.000986	CcSEcCtD
Trandolapril—Pruritus—Methotrexate—bone cancer	0.000984	0.000985	CcSEcCtD
Trandolapril—Hypersensitivity—Epirubicin—bone cancer	0.000959	0.00096	CcSEcCtD
Trandolapril—Urticaria—Doxorubicin—bone cancer	0.000957	0.000957	CcSEcCtD
Trandolapril—Body temperature increased—Doxorubicin—bone cancer	0.000953	0.000953	CcSEcCtD
Trandolapril—Abdominal pain—Doxorubicin—bone cancer	0.000953	0.000953	CcSEcCtD
Trandolapril—Diarrhoea—Methotrexate—bone cancer	0.000952	0.000952	CcSEcCtD
Trandolapril—Asthenia—Epirubicin—bone cancer	0.000934	0.000935	CcSEcCtD
Trandolapril—Pruritus—Epirubicin—bone cancer	0.000921	0.000922	CcSEcCtD
Trandolapril—Dizziness—Methotrexate—bone cancer	0.00092	0.00092	CcSEcCtD
Trandolapril—Diarrhoea—Epirubicin—bone cancer	0.000891	0.000891	CcSEcCtD
Trandolapril—Hypersensitivity—Doxorubicin—bone cancer	0.000888	0.000888	CcSEcCtD
Trandolapril—Vomiting—Methotrexate—bone cancer	0.000885	0.000885	CcSEcCtD
Trandolapril—Rash—Methotrexate—bone cancer	0.000877	0.000878	CcSEcCtD
Trandolapril—Dermatitis—Methotrexate—bone cancer	0.000877	0.000877	CcSEcCtD
Trandolapril—Headache—Methotrexate—bone cancer	0.000872	0.000872	CcSEcCtD
Trandolapril—Asthenia—Doxorubicin—bone cancer	0.000865	0.000865	CcSEcCtD
Trandolapril—Dizziness—Epirubicin—bone cancer	0.000861	0.000861	CcSEcCtD
Trandolapril—Pruritus—Doxorubicin—bone cancer	0.000852	0.000853	CcSEcCtD
Trandolapril—Vomiting—Epirubicin—bone cancer	0.000828	0.000828	CcSEcCtD
Trandolapril—Nausea—Methotrexate—bone cancer	0.000827	0.000827	CcSEcCtD
Trandolapril—Diarrhoea—Doxorubicin—bone cancer	0.000824	0.000825	CcSEcCtD
Trandolapril—Rash—Epirubicin—bone cancer	0.000821	0.000821	CcSEcCtD
Trandolapril—Dermatitis—Epirubicin—bone cancer	0.00082	0.000821	CcSEcCtD
Trandolapril—Headache—Epirubicin—bone cancer	0.000816	0.000816	CcSEcCtD
Trandolapril—Dizziness—Doxorubicin—bone cancer	0.000797	0.000797	CcSEcCtD
Trandolapril—Nausea—Epirubicin—bone cancer	0.000774	0.000774	CcSEcCtD
Trandolapril—Vomiting—Doxorubicin—bone cancer	0.000766	0.000766	CcSEcCtD
Trandolapril—Rash—Doxorubicin—bone cancer	0.00076	0.00076	CcSEcCtD
Trandolapril—Dermatitis—Doxorubicin—bone cancer	0.000759	0.000759	CcSEcCtD
Trandolapril—Headache—Doxorubicin—bone cancer	0.000755	0.000755	CcSEcCtD
Trandolapril—Nausea—Doxorubicin—bone cancer	0.000716	0.000716	CcSEcCtD
Trandolapril—ACE—forelimb—bone cancer	6.11e-05	0.222	CbGeAlD
Trandolapril—ACE—hindlimb—bone cancer	5.5e-05	0.2	CbGeAlD
Trandolapril—ACE—arm—bone cancer	5.25e-05	0.191	CbGeAlD
Trandolapril—ACE—appendage—bone cancer	4.72e-05	0.171	CbGeAlD
Trandolapril—CES1—connective tissue—bone cancer	2.02e-05	0.0735	CbGeAlD
Trandolapril—ACE—connective tissue—bone cancer	1.35e-05	0.0489	CbGeAlD
Trandolapril—ACE—bone marrow—bone cancer	8.96e-06	0.0326	CbGeAlD
Trandolapril—ACE—spinal cord—bone cancer	8.92e-06	0.0324	CbGeAlD
Trandolapril—SLC15A2—spinal cord—bone cancer	7.78e-06	0.0283	CbGeAlD
